VAERS reports by lot

GSK Varicella/Shingles lot 4N2AB: VAERS reports

36 VAERS reports list lot 4N2AB as a GSK Varicella/Shingles vaccine, received between 2021-07-01 and 2024-02-26. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
36
Reports
6%
Marked serious
0
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Dermatological (non-injection-site)921%
Injection-site / Local reaction921%
Cardiac / Cardiovascular717%
Gastrointestinal717%
Musculoskeletal37%
General / Systemic (non-local)37%
Allergic / Anaphylactic25%
Neurological12%
Thrombotic / Hematological12%

Where reports came from

U.S. state of the reporter, where given (top 12).

District of Columbia10
California3
Massachusetts2
New York2
Arizona2
Louisiana1
North Carolina1
Florida1
Illinois1
Nebraska1
Indiana1
New Jersey1

Reports by month received

2021-071
2021-083
2021-096
2021-104
2021-122
2022-011
2022-031
2022-042
2023-051
2023-126
2024-014
2024-025

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.